1-5 of about 5 matches for site:www.jci.org tirzepatide
https://www.jci.org/articles/view/194751
eligible for bariatric surgery. Modern GLP-1 medicines such as semaglutide and tirzepatide frequently result in
https://www.jci.org/review_series/134
development of orally available GLP-1RAs. A third incretin-based approach is tirzepatide, a dual
https://www.jci.org/review_series/131
in noninvasive biomarkers and personalized treatment approaches. Recent trials with agents such as semaglutide, tirzepatide, survodutide, lanifibranor, pegozafermin, and
https://www.jci.org/in-press-preview
food intake in mice The incretin receptor agonists semaglutide and tirzepatide have transformed the
https://www.jci.org/tags/58
in noninvasive biomarkers and personalized treatment approaches. Recent trials with agents such as semaglutide, tirzepatide, survodutide, lanifibranor, pegozafermin, and